Table 1.

Lists primary, secondary, and other endpoints included in the study in order to evaluate longitudinal changes in HRQOL and adherence.

Endpoint (mean difference EOT minus BL)	PRO measure
Primary endpoint	SF-12 PCS-12
Secondary endpoint	SF-12 MCS-12
	EQ-5D-5L
	SGRQ
	HADS
Other endpoint	Clinical data (sputum smear)
	MMAS-8